Antibacterial solid composition for oral administration
Patent 4616008 Issued on October 7, 1986. Estimated Expiration Date: 
April 29, 2005. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
April 29, 2005. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesInclusion compound of eicosapentaenoic acid or docosahexaenoic acid with cyclodextrin Inclusion compound of lankacidin-group antibiotic and use thereof Patent #: 4497803 InventorsAssigneeApplicationNo. 06/728502 filed on 04/29/1985US Classes:514/200, 1-thia-5-aza-bicyclo (4.2.0) octane ring containing (including dehydrogenated) (e.g., cephalosporins, etc.)514/777Carbohydrate or lignin, or derivativeExaminersPrimary: Friedman, Stanley J.Attorney, Agent or FirmInternational ClassesA61K 47/48 (20060101)A61K 47/40 (20060101) A61K 31/545 (20060101) C08B 37/00 (20060101) Foreign Application Priority Data1984-05-02 JPAbstractThis invention relates to an antibacterial solid composition for oral administration which comprises a lipid soluble cephalosporin compound and a cyclodextrin. The said composition provides much increased in vivo absorbability of a non-ester form of the cephalosporin compound. This composition is useful for prevention and treatment of bacterial infections.Other References
Field of SearchCarbohydrate or lignin, or derivative | |
